572 followers
RT @BiotechFQ: $IPSC Two companies, Century Therapeutics and CytoMed Therapeutics, have developed platforms that enrich #γδT cells from hea…
1,239 followers
RT @BiotechFQ: $IPSC Two companies, Century Therapeutics and CytoMed Therapeutics, have developed platforms that enrich #γδT cells from hea…
301 followers
$IPSC Two companies, Century Therapeutics and CytoMed Therapeutics, have developed platforms that enrich #γδT cells from healthy donor leukapheresis and then reprogram them. https://t.co/5J0tRkGVCt
49 followers
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy https://t.co/AKjbW6PqOd #FrontImmunol